دورية أكاديمية

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

التفاصيل البيبلوغرافية
العنوان: Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
المؤلفون: Laurence Albiges, Bernard Escudier, Catherine Sautes-Fridman, Benoit Beuselinck, Lydie Cassard, Maxime Meylan, Nathalie Rioux-Leclercq, Aude Desnoyer, Guillaume Lacroix, Nathalie Chaput-Gras, Marie Naigeon, Lisa Boselli, Salem Chouaib, Lucia Carril-Ajuria, Cécile Dalban, Yann Vano, Sylvie Chabaud, Janice Barros-Monteiro, Antoine Bougoüin, Irelka Colina-Moreno, Florence Tantot, Caroline De Oliveira, Wolf Herve Fridman
المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
بيانات النشر: BMJ Publishing Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Background The phase II NIVOREN GETUG-AFU 26 study reported safety and efficacy of nivolumab in patients with metastatic clear cell renal cell carcinoma (m-ccRCC) in a ‘real-world setting’. We conducted a translational-research program to determine whether specific circulating immune-cell populations and/or soluble factors at baseline were predictive of clinical outcomes in patients with m-ccRCC treated with nivolumab within the NIVOREN study.Methods Absolute numbers of 106 circulating immune-cell populations were prospectively analyzed in patients treated at a single institution within the NIVOREN trial with available fresh-whole-blood, using dry formulation panels for multicolor flow cytometry. In addition, a panel of 14 predefined soluble factors was quantified for each baseline plasma sample using the Meso-Scale-Discovery immunoassay. The remaining patients with available plasma sample were used as a validation cohort for the soluble factor quantification analysis. Tumor immune microenvironment characterization of all patients included in the translational program of the study was available. The association of blood and tissue-based biomarkers, with overall survival (OS), progression-free survival (PFS) and response was analyzed.Results Among the 44 patients, baseline unswitched memory B cells (NSwM B cells) were enriched in responders (p=0.006) and associated with improved OS (HR=0.08, p=0.002) and PFS (HR=0.54, p=0.048). Responders were enriched in circulating T follicular helper (Tfh) (p=0.027) and tertiary lymphoid structures (TLS) (p=0.043). Circulating NSwM B cells positively correlated with Tfh (r=0.70, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2051-1426
العلاقة: https://jitc.bmj.com/content/10/5/e004885.fullTest; https://doaj.org/toc/2051-1426Test
DOI: 10.1136/jitc-2022-004885
الوصول الحر: https://doaj.org/article/3b8448255849403eaa7f2df395db9ee2Test
رقم الانضمام: edsdoj.3b8448255849403eaa7f2df395db9ee2
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20511426
DOI:10.1136/jitc-2022-004885